证券研究报告 | 首次覆盖报告 gszqdatemark 2025 06 20 年 月 日 矩阵股份（301365.SZ） 云图藏器，智启新境 优质室内创意设计龙头，资产质量优异。公司业务聚焦室内装饰设计领域， 覆盖空间设计、软装陈设两大板块，下游行业以地产为主，同时积极开拓 办公空间、酒店文旅等多业态。2024 年公司减值规模显著收窄，地产减值 高峰已过，随着营收逐步恢复稳增，业绩有望稳步修复。公司毛利率、现 金流等指标表现优异，2024 年净现比 407%，截至 2024 年末在手现金资 产超 15 亿元（最新市值 29 亿元），有息负债率仅 2%，安全边际充足。 室内设计属地产后周期产业，近两年行业需求有所收缩。室内设计为装饰 工程前端环节，需求主要受房地产新开工数据影响，基于 2024 年新开工 面积测算行业市场总规模约 969 亿元。2020 年以来新开工面积已连续 5 年下滑，后端设计、房建、装饰需求同步收缩，上市 13 家房建设计院 2024 年营收/归母净利润总额同降 18%/130%，龙头经营承压。从竞争格局看， 受制于管理瓶颈及非标用户需求，设计龙头较难实现规模持续扩张，行业 整体格局分散 ...

Group 1 - Chengjian Development received a dividend of 7.1282 million yuan from Beijing Jingcheng Jiaye Property Co., Ltd., in which it holds a 33.47% stake [1] - Shengnuo Bio expects a net profit attributable to shareholders of 77.0275 million to 94.1448 million yuan for the first half of 2025, representing a year-on-year increase of 253.54% to 332.10% [1] - JKN2301 dry mixed suspension has been approved for clinical trials, targeting children with influenza [5][6] Group 2 - Jindawei obtained a patent for a method of purifying natto kinase, with a validity of twenty years [2] - CITIC Guoan plans to increase its stake in China Broadcasting Hunan Company to approximately 5.29% through a capital increase of 278 million yuan [2] - Ji Electric announced the resignation of its general manager, Niu Guojun, due to work changes [3] Group 3 - Xintian Green Energy successfully issued 1.5 billion yuan in green medium-term notes with a term of 3+N years and an interest rate of 2.05% [7] - Hengrun Co. plans to invest 1.2 billion yuan in a project to produce 2,000 sets of wind turbine gearbox components [9] - Pulaide received a government subsidy of 10 million yuan, accounting for 15.87% of its audited net profit for the last fiscal year [10] Group 4 - Boteng Co. passed the EU QP audit, receiving a compliance statement for its CDMO services [12] - Zhou Dasheng added 7 self-operated stores in May, with total investments ranging from 900,000 to 6.5 million yuan [13] - Wantai Bio initiated a Phase III clinical trial for its live attenuated varicella vaccine [15] Group 5 - Shanghai Pharmaceuticals received a drug registration certificate for Pregabalin capsules in Thailand [19] - Sanxing Medical's subsidiary is expected to win contracts worth approximately 143 million yuan from State Grid projects [21] - Jiangsu Huachen plans to issue 460 million yuan in convertible bonds [24] Group 6 - Jian Gong Repair won a soil pollution remediation project worth 32.76 million yuan [25] - Dize Pharmaceutical completed patient enrollment for a global Phase III clinical trial of its drug [26] - Del Co. received acceptance for its application to issue shares for asset acquisition and raise matching funds [27] Group 7 - Beijing Kerui won multiple power grid projects with a total value of approximately 154 million yuan [27] - Xie Chuang Data signed financing lease contracts totaling 498 million yuan with Su Yin Financial Leasing [28] - Meige Intelligent submitted an application for H-share listing on the Hong Kong Stock Exchange [29][31] Group 8 - Aikodi plans to repurchase shares worth 100 million to 200 million yuan for employee stock ownership plans [54] - Kong Kong Industrial intends to sell 80% of Tianyuan Construction to its controlling shareholder [55] - Youyou Green Energy proposed a cash dividend of 12 yuan per 10 shares, totaling 50.4 million yuan [55]

威领股份：控股孙公司2.2亿元竞得嘉宇矿业74.3%股权 5月21日，威领股份（002667）发布公告称，控股孙公司天津长领矿业合伙企业（有限合伙）在京东资 产交易平台以2.2亿元竞得湖南临武嘉宇矿业有限责任公司74.3%的股权。嘉宇矿业主要从事有色金属 矿、黑色金属矿的采矿、选矿及冶炼等业务，拥有丰富的矿产资源储量。 资料显示，威领股份成立于1994年10月，主营业务是锂矿选矿、基础性锂电原料锂盐加工及冶炼业务。 所属行业：机械设备–专用设备–能源及重型设备 中农立华：拟收购台州农资不少于50%股份 5月21日，中农立华（603970）发布公告称，公司与陶维康等浙江省台州市农资股份有限公司（简称"台 州农资"）自然人股东签署股份收购意向书，拟以现金或其他方式收购陶维康等自然人股东持有的台州 农资不少于50%股份。收购完成后，台州农资将成为公司的控股子公司。 所属行业：基础化工–农化制品–农药 潮宏基：正筹划在香港联交所发行H股上市事项 5月21日，潮宏基（002345）发布公告称，公司目前正筹划在香港联交所发行H股上市事项，相关细节 和方案尚未确定。目前公司生产经营情况正常，内外部经营环境未发生重大变化。 ...

Investment Rating - The report maintains a "Buy" rating for the company [5] Core Views - The company is experiencing a revenue decline of 4.4% in 2024, but the decline is narrowing compared to 2023, indicating a potential recovery point in performance [1] - The company is transitioning from an "engineering consulting" model to a "comprehensive technical service" model, focusing on optimizing customer structure and reducing reliance on high-risk clients [3] - The company expects significant growth in net profit from 2025 to 2027, with projected increases of 264%, 51%, and 21% respectively [3] Financial Performance Summary - In 2024, the company achieved total revenue of 470 million, down 4.4% year-on-year, with a net profit attributable to shareholders of -26 million, a decline of 162.8% [4] - The gross margin for 2024 is 36.6%, down 3.2 percentage points, primarily due to intense competition in the real estate evaluation market and rigid cost structures [2] - The company reported a net profit margin of -5.5% in 2024, a decrease of 14 percentage points year-on-year [2] Business Segment Analysis - Revenue from third-party evaluations and project management was 280 million and 190 million respectively in 2024, with year-on-year changes of -12% and +10% [1] - The company has successfully reduced the proportion of revenue from real estate clients from 90% to 46% by expanding into industries such as insurance and overseas markets [3] Future Projections - The company forecasts total revenue of 526 million in 2025, representing a year-on-year growth of 12.1% [4] - The expected earnings per share (EPS) for 2025 is 0.28 yuan, with a projected price-to-earnings (P/E) ratio of 59.8 [4]